Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Rep. Leonard Lance

BioNJ Gala Speaker Predicts 21st Century ‘Cracking of Biology Nut’; Leaders Honored

Newark, NJ, February 3, 2017 — In what has become one of the top New Jersey life sciences events, the trade organization BioNJ last night held its 24th annual dinner meeting, networking event and innovation celebration at the Hilton East Brunswick, with some 650 people in attendance, reports George N. Saliba in New Jersey Business.

Rousing speeches by the likes of life sciences icon Fred Hassan, and, separately, journalist extraordinaire Joan Lunden, underscored the order-of-magnitude progress being made in the life sciences arena. Continue reading

Congress Members’ Cancer Experiences Could Forge Bipartisan Policy, Spur Support for Biden’s Cancer ‘Moonshot’ Initiative

Capitol Building flagWashington, DC, March 15, 2016 ― Lindsey McPherson reports in Roll Call that few issues are as ripe for bipartisanship as fighting cancer, a disease that has touched nearly every family, including members of Congress.

“When you bring it down to a personal level, I think it’s a lot easier to get people on the bandwagon and get them cheerleading and say, ‘Hey, we’re going to beat this, and we need to do it today instead of tomorrow,’” said Rep. Billy Long, R-Mo., whose daughter went through treatment last year for non-Hodgkin’s lymphoma.

McPherson reports that Democrats are hoping that view will persuade Republicans to support Vice President Joseph R. Biden Jr.’s “moonshot” task force, which aims to accelerate cancer research to the point that a decade’s worth of progress can be accomplished in half the time. Continue reading

Reps. Payne, Lance, and Colleagues Introduce Resolution Designating March 2016 as National Colorectal Cancer Awareness Month

(L. to r.) Congressmen Donald Payne, Jr. and Leonard Lance

(L. to r.) Congressmen Donald Payne, Jr. and Leonard Lance

Washington, DC, March 4, 2016 ― Congressman Donald M. Payne, Jr. (NJ-10), Congressman Leonard Lance (NJ-7), and colleagues introduced a House resolution (H.Res.630) to designate March 2016 as National Colorectal Cancer Awareness Month.

The resolution aims to have the House support the goals and ideals of National Colorectal Cancer Awareness Month and encourage the people of the United States to observe the month with appropriate awareness and educational activities.

“I’m proud to introduce this resolution to designate March 2016 as National Colorectal Cancer Awareness Month.  Today and every day, colorectal cancer survivors, their families, and advocacy groups deserve to be honored for their contributions to fighting this disease,” said Congressman Payne, Jr. Continue reading

Reps. Lance and Peters Launch Congressional Life Science Caucus

Washington, DC, November 4, 2015 ― U.S. Representatives Scott Peters (D, CA-52) and Leonard Lance (R, NJ-07) on October 27 launched the Congressional Life Science Caucus.

“The life sciences are driving innovative breakthroughs that are saving lives and changing the face of medicine in our country,” said Congressman Peters.   Continue reading

Rep. Lance Receives HINJ’s 2015 Bob Franks Public Service Award

(L. to r.) Rep. Leonard Lance, Fran Franks, Abby Franks, Sara Franks, HINJ CEO Dean Paranicas, and Craig Bleifer, VP, General Counsel and Secretary, Daiichi Sankyo and HINJ Board Chair

(L. to r.) Rep. Leonard Lance, Fran Franks, Abby Franks, Sara Franks, HINJ CEO Dean Paranicas, and Craig Bleifer, VP, General Counsel and Secretary, Daiichi Sankyo and Chair, HINJ Board of Trustees

Trenton, NJ, November 3, 2015 ― Congressman Leonard Lance (NJ-07) proudly accepted the Honorable Bob Franks Public Service Award from the HealthCare Institute of New Jersey on October 30  in a special ceremony in Trenton.

The HealthCare Institute of New Jersey (HINJ), a trade association for the research-based biopharmaceutical and medical technology industry, selected Lance for his accomplished record on public health matters and his work on the House Energy and Commerce Committee and its Health Subcommittee.

“Right now in laboratories across New Jersey exciting and groundbreaking treatments are being tested, vetted and envisioned.  I work in Congress to give these modern-day inventors the tools they need to research and develop 21st Century cures and therapies that will improve and save lives,” Lance told the crowd at the annual celebration of New Jersey’s life science leaders.

Continue reading

HINJ Honors Four at Life Sciences Celebration 2015: Rep. Lance, Dr. Nils Lonberg, Deborah Brown and David Knowlton

hinj_logo_high_resNew Brunswick, NJ, October 30, 2015 ― The HealthCare Institute of New Jersey (HINJ) this morning honored four for their contributions in public service, life sciences research, patient advocacy and health care policy.  The awards were presented at HINJ’s Life Sciences Celebration 2015, which was held at the Wyndham Garden Trenton.

The recipients of HINJ’s 2015 honors were:

  • The Honorable Bob Franks Public Service Award:  HINJ presented the Honorable Bob Franks Public Service Award — named in honor of the late former U.S. Congressman and HINJ President and Chief Executive Officer Bob Franks — to U.S. Representative Leonard Lance (R-NJ-7) for his leadership in protecting patients and scientific research and the advancement of global human health.  Mr. Lance, a member of the House Committee on Energy and Commerce, played a key leadership role in passage of the House’s 21st Century Cures Act (H.R. 6) in July 2015. Continue reading

COUNTDOWN! HINJ to Host Life Sciences Celebration October 30; Four to Be Honored

hinj_logo_high_resNew Brunswick, NJ, October 28, 2015 ― The HealthCare Institute of New Jersey (HINJ) will honor meritorious leadership in and contributions to New Jersey’s life sciences community at its 2015 Life Sciences Celebration, which will be held Friday, October 30 at the Wyndham Garden Trenton from 8:00 to 10:00 a.m.

HINJ’s 2015 honorees will be:

  • The Honorable Bob Franks Public Service Award: Rep. Leonard Lance (R-7), Member, US House Energy and Commerce Committee
  • Research: Nils Lonberg, Ph.D., Senior Vice President, Oncology Discovery Biology, Bristol-Myers Squibb Company

Event: HINJ to Host 2015 Life Sciences Celebration October 30; Honorees Named

hinj_logo_high_resNew Brunswick, NJ, September 18, 2015 ― The HealthCare Institute of New Jersey (HINJ) will honor meritorious leadership in and contributions to New Jersey’s life sciences community at its 2015 Life Sciences Celebration, which will be held Friday, October 30 at the Wyndham Garden Trenton from 8:00 to 10:00 a.m.

HINJ’s 2015 honorees will be:

  • The Honorable Bob Franks Public Service Award: Rep. Leonard Lance (R-7), Member, US House Energy and Commerce Committee
  • Research: Nils Lonberg, Ph.D., Senior Vice President, Oncology Discovery Biology, Bristol-Myers Squibb Company
  • Patient Advocacy: Deborah Brown, President and Chief Executive Officer, American Lung Association of the Mid-Atlantic

Continue reading

Congressman Lance Hails Passage of 21st Century Cures Act; Lance-Eshoo Language on User Fees Included in Bill

Leonard Lance

U.S. Rep. Leonard Lance (R-7)

Washington, DC, July 13, 2015 ― Congressman Leonard Lance (NJ-07) on Friday hailed U.S. House of Representatives’ passage of H.R. 6, the 21st Century Cures Act, landmark legislation to modernize our health care system, encourage innovation, support research and streamline drug and device approval.

“Millions of Americans await the genius of 21st Century innovation that is being slowed by a regulatory rules  from the last century,” said Lance, a member of the House Energy and Commerce Committee tasked with crafting the legislation.

“The 21st Century Cures legislation will open the path to new medicines, improving the quality of life for millions of Americans and enhancing our Nation’s role as the global leader in research and development of the cures for tomorrow,” Congressman Lance said. Continue reading

NJ Spotlight: House’s Cures 2015 Bill Holds Promise for ‘Personalized Medicine’

Montclair, NJ, May 26, 2015 ― Andrew Kitchenman reports in NJ Spotlight that the U.S. House’s 21st Century Cures Act is attracting bipartisan support — including from New Jersey sponsors Reps. Frank Pallone (D-6)  and Leonard Lance (R-7) — and draws praise across New Jersey’s research community, as well as its biotechnology and pharmaceutical industries.

They see its goals of increasing medical research funding and speeding the approval of new drugs and medical devices as essential to promoting therapies that will serve patients and promote the state’s biotech and pharma companies.

Lance sponsored a section of the bill that would ease limits on the amount of money that the Food and Drug Administration can spend to test drugs.  That would increase the speed at which the FDA can approve drugs. Continue reading